✦ LIBER ✦

Murine Models of Cancer Cytokine Gene Therapy Using Interleukin-12

✍ Scribed by HIDEAKI TAHARA; LAURENCE ZITVOGEL; WALTER J. STORKUS; PAUL D. ROBBINS; MICHAEL T. LOTZE

Book ID: 119873628
Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 548 KB
Volume: 795
Category: Article
ISSN: 0890-6564
DOI: 10.1111/j.1749-6632.1996.tb52677.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytokine Gene Therapy of Cancer Using In

Cytokine Gene Therapy of Cancer Using Interleukin-12: Murine and Clinical Trials

✍ MICHAEL T. LOTZE; LAURENCE ZITVOGEL; RONNA CAMPBELL; PAUL D. ROBBINS; ELAINE ELD 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 922 KB

Application of interleukin 12 to antitum

Application of interleukin 12 to antitumor cytokine and gene therapy

✍ T. Nishimura; Kazuhito Watanabe; Takashi Yahata; L. Ushaku; Kiyoshi Ando; Minoru 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 257 KB

Intravesical interleukin-12 gene therapy

Intravesical interleukin-12 gene therapy in an orthotopic bladder cancer model

✍ Minoru Horinaga; Kelley M. Harsch; Ryuichi Fukuyama; Warren Heston; William Larc 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Intravesical liposome-mediated interleuk

Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model

✍ Horiguchi, Y; Larchian, W A; Kaplinsky, R; Fair, W R; Heston, W D W 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 261 KB

Treatment of disseminated ovarian cancer

Treatment of disseminated ovarian cancer using nonviral interleukin-12 gene therapy delivered intraperitoneally

✍ Jason G. Fewell; Majed M. Matar; Jennifer S. Rice; Elaine Brunhoeber; Gregory Sl 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB

## Abstract ## Background The poor prognosis associated with ovarian cancer is primarily the result of delayed diagnosis and the lack of an effective treatment for advanced disease. Use of novel immunotherapy strategies are being evaluated that work to enhance local and systemic immune responses a

Murine interleukin-12 prevents the devel

Murine interleukin-12 prevents the development of cancer cachexia in a murine model

✍ Kazushige Mori; Kaori Fujimoto-Ouchi; Tohru Ishikawa; Fumiko Sekiguchi; Hideo Is 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 744 KB

Murine colon 26 carcinoma causes cachexia even when the tumor burden is small. In this tumor model, murine IL-I2 suppressed the induction of cancer cachexia and also inhibited tumor growth. IL-I2 reduced the serum levels of IL-6, a cachexia mediator in this model, and alleviated the body weight loss